Studies towards a pan-genome and genetic manipulation of Clostridium scindens

梭菌的全基因组和遗传操作研究

基本信息

项目摘要

Project Summary Recent studies suggest that Clostridium scindens is protective against C. difficile infection in vivo. Antibiotic- induced dysbiosis results in altered bile acid profile which is thought to allow C. difficile to grow and cause infection. Prior studies have shown that host bile acids such as taurocholic acid induce C. difficile spore germination in the GI tract; whereas conversion of host bile acids to secondary bile acids such as deoxycholic acid (DCA) by C. scindens prevents C. difficile spore germination and vegetative cell growth. However, a genetic system is currently lacking in C. scindens, representing a barrier to demonstrating causation with respect to DCA formation and inhibition of C. difficile growth and virulence. We have a collection of over a dozen strains of C. scindens strains whose genome sequences are not known. In Aim 1, we propose to sequence the complete genomes of these strains. We have already completed the genome/methylome of C. scindens ATCC 35704T. Determining the ‘pan-genome’ of C. scindens will allow determination of strain variation, and may allow identification of strains more susceptible to genetic manipulation. We will also perform transcriptomic analysis with two C. scindens strains in a newly developed defined medium and identify genes differentially expressed in the presence of bile acids. In Aim 2 we test the hypothesis that the barrier to genetic manipulation of C. scindens is restriction modification (FM) systems. Methylome data has identified extensive m6A modification among conserved sequences in the genome. We will utilize a plasmid artificial modification (PAM) approach to developing a pyrE counter-selectable marker. These studies will provide substantial progress in the understanding of Clostridium scindens biology, bile acid metabolism, and significant progress towards genetic manipulation of C. scindens. This will allow future proposals aimed at testing the hypothesis that DCA formation by C. scindens protects against C. difficile infection in vivo.
项目概要 最近的研究表明,Clostridium scindens 对体内艰难梭菌感染具有保护作用。抗生素- 诱导的生态失调导致胆汁酸谱改变,这被认为允许艰难梭菌生长并导致 感染。先前的研究表明,牛磺胆酸等宿主胆汁酸会诱导艰难梭菌孢子 在胃肠道中发芽;而宿主胆汁酸转化为次级胆汁酸,例如脱氧胆酸 C. scindens 产生的酸 (DCA) 可阻止艰难梭菌孢子萌发和营养细胞生长。然而,一种遗传 目前 C. scindens 中缺乏该系统,这对于证明 DCA 的因果关系构成了障碍 艰难梭菌生长和毒力的形成和抑制。我们收集了十多个 C. scindens 菌株的基因组序列未知。在目标 1 中,我们建议对完整的 这些菌株的基因组。我们已经完成了 C. scindens ATCC 35704T 的基因组/甲基化组。 确定 C. scindens 的“泛基因组”将允许确定菌株变异,并可能允许 鉴定对基因操作更敏感的菌株。我们还将进行转录组分析 在新开发的特定培养基中使用两种 C. scindens 菌株,并鉴定差异表达的基因 胆汁酸的存在。在目标 2 中,我们检验了 C. scindens 遗传操作障碍的假设 是限制修改(FM)系统。甲基化组数据已鉴定出广泛的 m6A 修饰 基因组中的保守序列。我们将利用质粒人工修饰(PAM)方法 开发pyrE反选择标记。这些研究将在以下方面取得实质性进展: 了解梭菌生物学、胆汁酸代谢以及遗传学方面的重大进展 C. scincens 的操纵。这将允许未来的提案旨在测试 DCA 形成的假设 C. scindens 可以防止体内艰难梭菌感染。

项目成果

期刊论文数量(6)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Gut feelings about bacterial steroid-17,20-desmolase.
Formation of secondary allo-bile acids by novel enzymes from gut Firmicutes.
  • DOI:
    10.1080/19490976.2022.2132903
  • 发表时间:
    2022-01
  • 期刊:
  • 影响因子:
    12.2
  • 作者:
  • 通讯作者:
Complete genome sequence of the archetype bile acid 7α-dehydroxylating bacterium, Clostridium scindens VPI12708, isolated from human feces, circa 1980.
原型胆汁酸7α-脱羟基化细菌的完整基因组序列,梭状芽胞杆菌scindens vpi12708,从人粪便中分离出来,大约1980年。
The Hylemon-Björkhem pathway of bile acid 7-dehydroxylation: history, biochemistry, and microbiology.
  • DOI:
    10.1016/j.jlr.2023.100392
  • 发表时间:
    2023-08
  • 期刊:
  • 影响因子:
    6.5
  • 作者:
    Ridlon JM;Daniel SL;Gaskins HR
  • 通讯作者:
    Gaskins HR
Microbial Hydroxysteroid Dehydrogenases: From Alpha to Omega.
  • DOI:
    10.3390/microorganisms9030469
  • 发表时间:
    2021-02-24
  • 期刊:
  • 影响因子:
    4.5
  • 作者:
    Doden HL;Ridlon JM
  • 通讯作者:
    Ridlon JM
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Jason Michael Ridlon其他文献

Jason Michael Ridlon的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Jason Michael Ridlon', 18)}}的其他基金

Gut bacterial metabolism of the side-chain of corticosteroids
皮质类固醇侧链的肠道细菌代谢
  • 批准号:
    10703384
  • 财政年份:
    2022
  • 资助金额:
    $ 7.54万
  • 项目类别:
Role of Gut Bacterial Side-Chain Cleavage of Cortisol in Host 11Beta-Hydroxyandrostenedione Formation
肠道细菌皮质醇侧链裂解在宿主 11β-羟基雄烯二酮形成中的作用
  • 批准号:
    10726864
  • 财政年份:
    2020
  • 资助金额:
    $ 7.54万
  • 项目类别:
Role of Gut Bacterial Side-Chain Cleavage of Cortisol in Host 11Beta-Hydroxyandrostenedione Formation
肠道细菌皮质醇侧链裂解在宿主 11β-羟基雄烯二酮形成中的作用
  • 批准号:
    10594989
  • 财政年份:
    2020
  • 资助金额:
    $ 7.54万
  • 项目类别:
Role of Gut Bacterial Side-Chain Cleavage of Cortisol in Host 11Beta-Hydroxyandrostenedione Formation
肠道细菌皮质醇侧链裂解在宿主 11β-羟基雄烯二酮形成中的作用
  • 批准号:
    10370361
  • 财政年份:
    2020
  • 资助金额:
    $ 7.54万
  • 项目类别:
Studies towards a pan-genome and genetic manipulation of Clostridium scindens
梭菌的全基因组和遗传操作研究
  • 批准号:
    9979542
  • 财政年份:
    2020
  • 资助金额:
    $ 7.54万
  • 项目类别:
Characterization of bacterial reductases acting on the A-ring of 11-oxy-androgens
作用于 11-氧雄激素 A 环的细菌还原酶的表征
  • 批准号:
    10653436
  • 财政年份:
    2020
  • 资助金额:
    $ 7.54万
  • 项目类别:

相似海外基金

Time to ATTAC: Adoptive Transfer of T cells Against gp100+ Cells to treat LAM
ATTAC 时间:针对 gp100 细胞的 T 细胞过继转移来治疗 LAM
  • 批准号:
    10682121
  • 财政年份:
    2023
  • 资助金额:
    $ 7.54万
  • 项目类别:
Phase I clinical trial of adoptive transfer of autologous folate receptor-alpha redirected CAR T cells for ovarian cancer
自体叶酸受体-α重定向CAR T细胞过继转移治疗卵巢癌的I期临床试验
  • 批准号:
    10576370
  • 财政年份:
    2022
  • 资助金额:
    $ 7.54万
  • 项目类别:
Phase I clinical trial of adoptive transfer of autologous folate receptor-alpha redirected CAR T cells for ovarian cancer
自体叶酸受体-α重定向CAR T细胞过继转移治疗卵巢癌的I期临床试验
  • 批准号:
    10387023
  • 财政年份:
    2022
  • 资助金额:
    $ 7.54万
  • 项目类别:
Determining mechanisms of enhanced antitumor efficacy of four-day expanded Th17 cells for adoptive transfer
确定用于过继转移的四天扩增 Th17 细胞增强抗肿瘤功效的机制
  • 批准号:
    10248409
  • 财政年份:
    2019
  • 资助金额:
    $ 7.54万
  • 项目类别:
A phase I clinical study of adoptive transfer of regulatory T cells (Tregs) and low-dose interleukin-2 (IL-2) for the treatment of chronic graft-versus-host disease (GVHD): gene-marking to inform rational combination therapy
调节性 T 细胞 (Treg) 和低剂量白细胞介素 2 (IL-2) 过继转移治疗慢性移植物抗宿主病 (GVHD) 的 I 期临床研究:基因标记为合理的联合治疗提供信息
  • 批准号:
    nhmrc : GNT1163111
  • 财政年份:
    2019
  • 资助金额:
    $ 7.54万
  • 项目类别:
    Project Grants
Determining mechanisms of enhanced antitumor efficacy of four-day expanded Th17 cells for adoptive transfer
确定用于过继转移的四天扩增 Th17 细胞增强抗肿瘤功效的机制
  • 批准号:
    10462684
  • 财政年份:
    2019
  • 资助金额:
    $ 7.54万
  • 项目类别:
Gene edited lymphoid progenitors for adoptive transfer as a treatment of primary immunodeficiency
基因编辑的淋巴祖细胞用于过继转移作为原发性免疫缺陷的治疗
  • 批准号:
    398018062
  • 财政年份:
    2018
  • 资助金额:
    $ 7.54万
  • 项目类别:
    Research Grants
Overcoming immune suppression in cancer by targeting PSGL-1 in T cells used for adoptive transfer
通过靶向用于过继转移的 T 细胞中的 PSGL-1 克服癌症中的免疫抑制
  • 批准号:
    9308643
  • 财政年份:
    2017
  • 资助金额:
    $ 7.54万
  • 项目类别:
Overcoming immune suppression in cancer by targeting PSGL-1 in T cells used for adoptive transfer
通过靶向用于过继转移的 T 细胞中的 PSGL-1 克服癌症中的免疫抑制
  • 批准号:
    9447149
  • 财政年份:
    2017
  • 资助金额:
    $ 7.54万
  • 项目类别:
Targeting Cancer miRNAs by Adoptive Transfer of Programmed B Lymphocytes
通过程序化 B 淋巴细胞的过继转移靶向癌症 miRNA
  • 批准号:
    8893915
  • 财政年份:
    2014
  • 资助金额:
    $ 7.54万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了